Over 1,000 Companies Apply as the Fifth Future Healthcare 100 Strong Enterprises List Nominations Conclude Successfully

The historic year 2020 is now in the past, and the path of transformation has alreadyAnchoringAlright, a brand-new starting point; the new world order of the future isRemodelingAmidst this wave of historical transition, the healthcare industry is striving to craft an extraordinary and remarkable narrative, while China’s medical industry has ascended to new heights.

These pioneers, working quietly behind the scenes to open new paths in the industry, are an emerging force breaking through the darkness before dawn; they are the innovative enterprises truly leading China’s development direction in the new era of medical innovation. Building on technological innovation and upgrades, they have achieved a leap forward in high-quality services. Against the backdrop of shifting public perceptions, they are subtly transforming our lives and uncovering replicable patterns for medical transformation.

Launched in 2015, the Future Healthcare Top 100 is the first ranking list in China targeting non-listed companies in the innovative healthcare sector, introduced by VCBeat and VBInsight. It aims to select true innovators representing the future of healthcare, identify core forces within the future healthcare industry, and promote innovation and transformation in the health and medical sectors. Since its inception, the list has become a barometer for investment in the medical and health fields, guiding development and investment trends in China’s healthcare innovation sector both currently and in the foreseeable future, while providing reference and guidance for subsequent financing rounds of innovative enterprises.

Among the companies listed in 2019, Allist, BioCapital, Antengene, Gracell Biotechnologies, JD Health, Harbour BioMed, Jacobio Pharmaceuticals, Alphamab Oncology, Kintor Pharmaceutical, Konzen Medical, InnoCare Pharma, Peijia Medical, Frontier Biotechnologies, Sansure Biotech, SinoCellTech, I-Mab, Elevation Oncology, MicroPort CardioFlow, Lead Discovery Center, Yidu Cloud, JW Therapeutics, and Zai Lab have already22Companies have successively completed their IPOs and graduated from the Top 100 list.

Moreover, according to incomplete statistics from VB100, more than126Following the release of the 2019 rankings, listed companies successively secured new rounds of financing, exceeding42Cumulative Financing of Listed Companies500 millionRMB and above, cumulative financing amountOver RMB 65 billion(excluding listed companies), with a total valuation (excluding the overseas list) reaching1,181.77 billionRMB. The number of Series A companies is decreasing, while the number of companies post-Series C is increasing, indicating an overall shift toward later-stage financing rounds.Healthcare Services, Innovative PharmaceuticalsIt remains the sector where listed companies have secured the largest amounts of financing.

February 28, 2021, lasting6 monthsThe call for entries for the 5th "Top 100 Future Healthcare Companies" list has successfully concluded, with a cumulative1000+Corporate Registration Application: Rankings will be determined based on core criteria, including valuations by investment institutions, cumulative funding amounts, corporate growth rates, creditworthiness, and reputation. The corporate rankings and awards are currently undergoing information verification and expert review.

Information Review and Refinement: March 1–March 14

Valuation Review and Due Diligence: March 15–March 21

Expert Review and Confirmation: March 22–March 28

Review Results Notification: March 29–April 2

The final list will be announced at the 5th Future Healthcare Top 100 Conference, held in Wujiang, Jiangsu Province, from April 16 to 18, 2021. All shortlisted and award-winning companies will be invited to attend the awards gala dinner.

Building on previous editions, this year’s awards have expanded the categories and increased the number of selections. For the first time, individual and institutional awards have been separated. Centered around the two major award programs—the Pengcheng Awards and the Weilan Awards—the selection highlights the leadership and innovative vitality driving the development of the healthcare industry. The Weilan Awards have newly addedEmerging Entrepreneurs, Emerging InvestorsTwo Major Individual Awards: Selecting Rising Stars from the Capital and Industry Sectors Who Represent the Future Direction of Healthcare Development

Pengcheng Award Registration Deadline: March 22

Registration Link:http://vcbeat-vb100.mikecrm.com/1tHmQ5x

Application Deadline for the Weilan Award (Non-Emerging Figures): March 22

Registration Link:http://vcbeat-vb100.mikecrm.com/jtvPPk8

Weilan Award (Emerging Talent) Registration Deadline: March 31

Registration Link:http://vcbeat-vb100.mikecrm.com/cIOPnRE

Since 2016, there have beenOver 1,500Potential innovative enterprises made the list, with 19 already on it in 2019.Over 500The inclusion of innovative enterprises on the list demonstrates that the annual “Top 100 Future Healthcare Companies” ranking not only reaffirms the industry’s development trends for the current year but also serves as a forecast for the healthcare sector’s growth in the coming year. Meanwhile, the “Top 100 Future Healthcare Conference,” an important companion event to the ranking, has made a significant comeback after a one-year hiatus due to the pandemic. It is officially scheduled to take place from April 16 to April 18, 2021, in Wujiang, Suzhou, Jiangsu Province.

The 5th Future Healthcare Top 100 Conference will also undergo a comprehensive upgrade in Wujiang, Suzhou. This marks VCBeat’s boldest initiative since its establishment six years ago. The conference will focus on the healthcare industry, emphasizing personal health, public health, the medical industry chain, and supportive infrastructure, while exploring broader possibilities in healthcare to achieve a full-scale upgrade of the Top 100 Conference. Aimed at addressing new developments in the medical and health sector, embracing emerging trends, gathering core industry forces, and driving transformative innovation in the healthcare industry.

Shiqing Chen| Member of the U.S. National Academy of Engineering, Supercomputing Expert

Song Yijun | Representative of the Government of Ontario, Canada; Commercial Counsellor, Embassy of Canada in China

Sun Baoqing| Chairman of the Guangdong Zhong Nanshan Medical Foundation

Chen Qiulin| Director, Health Economics Research Division, Institute of Population and Labor Economics, Chinese Academy of Social Sciences_

Nick Rodgers| Chairman of the South East Academic Medical Systems for Technology (SEAMSTEC), Chairman of Destiny Pharma

Wang Tianmiao| Professor at Beihang University

Wang Jingjing| Executive Director, Global Health Industry Innovation Center, Tsinghua University

Luo Zhangwei| Chief Scientist, Suzhou Smart Healthcare Innovation Center; formerly of Siemens China Research Institute, Suzhou BranchChief AI Scientist 

Jane Jin| Head of Oxford University's Technology Transfer Office, China Region

Zhi Zhang| Business Development Manager, Technology Division, UK Medical Research Council

Chen Fangxia| Director of Business Development, Asia Technology Transfer Centre, Western University, Canada

Kimon Angelides | Founder of Livongo & Vivante

Lei Juan| Deputy Director of the West China Transfer Center, West China Hospital, Sichuan University

Wei Xuejie| Vice President of Xuzhou Mining Group General Hospital

Ye Xin| Deputy Dean, Yilianzhong Beijing Research Institute

Wu Xia| Managing Director, CICC Capital

Zhang Man| Vice President, China Renaissance Capital

Wang Xiaohui| Managing Partner of Shengjing Jiacheng Fund of Funds

Hu Chuanwei| Vice President, Hengqin Jintou Group

Li Yuhui| Founding Managing Partner, Panlin Capital

Yu Zhengkun| Founding Partner, Jifeng Capital

Zhou Yi| Partner, Shenzhen Capital Group Health Industry Fund

Zhang Zhiling| Partner, Zhenghe Huitong Medical Investment

Tian Min| Partner at Yuanjing Capital

Tang Haofu| Chairman of Chuangrui Investment

Ren Bobing| Executive Director of Sinovation Ventures

Andrew Craig| WG Fund Partner

……

Top-Tier Guest Lineup—Led by Academicians and IEEE Fellows200+"Top-tier guests present the most cutting-edge medical technology, industry trends, and business innovations over three days."

Business Wisdom of Industry Leaders——10Strategic Launch by Leading Publicly Listed Companies: Insights into the Industry’s Future and Innovation Landscape

Global Perspective and Overseas Resources — FromUnited Kingdom, Israel, United States, Canada, Belgium, Germany, Denmark...and the industrial development trends and capital markets of multiple countries, linking high-quality overseas technological innovation projects

In-Depth Insights into Niche Sectors—Major Release10 copiesIndustry Research Series: Exploring Development Opportunities and Innovative Cases in Niche Sectors

Gathering the Core Forces of Future Healthcare — Release6 MajorTop 100 Lists and Awards, Converged1000+Unicorns and High-Potential Innovative Enterprises Jointly Explore Pathways for Innovation-Driven Development

Emphasizing Research Translation — Invitation10+Hospital Presidents, Researchers, and University Experts: Breaking Boundaries to Explore the Integration of Industry and Research

A Forward-Looking Capital Perspective——100+Featuring forward-looking investors from GP, LP, CVC, VC, PE, FA, and other financial institutions to gauge the direction of capital heat in the industry

Harnessing the Momentum of the Industrial Ecosystem——10+Ecosystem Conference of Investment Institutions and Industry Giants: Promoting the Integration and Fission of the Industrial Ecosystem